Inventor · disambiguated record
Jennifer Lachey
Also filed as: LACHEY JENNIFER
19 granted patents·21 pending applications·222 citations·filing 2010–2025
94Inventor score
Top patents by PatentIndex Score
40 records- 0196US11717558B2Nucleic acid molecules encoding activin receptor type IIA variantsKEROS THERAPEUTICS INC·Filed 2021·Granted Aug 8, 2023·6 cites·12 claims
- 0296US9617319B2ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapyACCELERON PHARMA INC·Filed 2014·Granted Apr 11, 2017·21 cites·24 claims
- 0396US8710016B2ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapySEEHRA JASBIR·Filed 2010·Granted Apr 29, 2014·29 cites·30 claims
- 0496US8138142B2Methods for increasing adiponectin in a patient in need thereofSEEHRA JASBIR·Filed 2010·Granted Mar 20, 2012·82 cites·17 claims
- 0595US12350313B2Activin receptor type IIa variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·3 cites·20 claims
- 0695US11884715B2Activin receptor type IIB variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2020·Granted Jan 30, 2024·6 cites·14 claims
- 0795US11090361B2Activin receptor type IIa variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2017·Granted Aug 17, 2021·11 cites·10 claims
- 0895US11013785B2Activin receptor type IIA variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2017·Granted May 25, 2021·12 cites·20 claims
- 0995US8765663B2Methods for increasing adiponectinSEEHRA JASBIR·Filed 2012·Granted Jul 1, 2014·38 cites·12 claims
- 1094US12269858B2Activin receptor type IIB variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·2 cites·13 claims
- 1192US11484573B2Activin receptor type IIa variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2018·Granted Nov 1, 2022·8 cites·23 claims
- 1291US12364737B2Activin receptor type IIA variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2020·Granted Jul 22, 2025·3 cites·11 claims
- 1381US12404313B2GDNF fusion polypeptides and methods of use thereofKEROS THERAPEUTICS INC·Filed 2024·Granted Sep 2, 2025·0 cites·15 claims
- 1479US2025312415A1Activin receptor type iia variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1575US11912750B2GDNF fusion polypeptides and methods of use thereofKEROS THERAPEUTICS INC·Filed 2017·Granted Feb 27, 2024·1 cites·19 claims
- 1671US2025206799A1Activin receptor type iib variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1771US2022041670A1Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapyACCELERON PHARMA INC·Filed 2021·Application pending·0 cites
- 1869US2021269494A1Methods for treating fatty liver diseaseACCELERON PHARMA INC·Filed 2020·Application pending·0 cites
- 1968US10968262B2Methods of increasing sarcolemmal utrophinACCELERON PHARMA INC·Filed 2017·Granted Apr 6, 2021·0 cites·10 claims
- 2067US2025270333A1Alk2 antibodies and methods of use thereofKEROS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2163US12331124B2ALK2 antibodies and methods of use thereofKEROS THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·13 claims
- 2261US2024252631A1Methods of using activin receptor type ii signaling inhibitorsKEROS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2360US2015056200A1Methods for increasing adiponectinACCELERON PHARMA INC·Filed 2014·Application pending·0 cites
- 2458US2024218061A1Methods of using activin receptor type ii signaling inhibitorsKEROS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2558US2019062392A1Methods for treating fatty liver diseaseACCELERON PHARMA INC·Filed 2018·Application pending·0 cites
- 2657US12440539B2Methods of using activin receptor type IIB variantsKEROS THERAPEUTICS INC·Filed 2022·Granted Oct 14, 2025·0 cites·10 claims
- 2757US2023372390A1Methods of treating lymphopeniaKEROS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2857US2023398118A1Methods of treating cardiovascular-related diseaseKEROS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2956US2023265162A1Methods of using activin receptor type iia variantsKEROS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3055US12458693B2Methods of treating iron overload with a BMP inhibitorKEROS THERAPEUTICS INC·Filed 2023·Granted Nov 4, 2025·0 cites·15 claims
- 3155US2025034148A1Methods of using alk2 inhibitorsKEROS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3253US2016318983A1Methods for treating fatty liver diseaseACCELERON PHARMA INC·Filed 2016·Application pending·0 cites
- 3353US2025282877A1Methods of using alk2 and alk3 antibodiesKEROS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3452US2024228583A1Activin receptor type ii chimeras and methods of use thereofKEROS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3552US2016264681A1Methods for increasing adiponectinACCELERON PHARMA INC·Filed 2016·Application pending·0 cites
- 3652US2011129469A1Methods for treating fatty liver diseaseACCELERON PHARMA INC·Filed 2010·Application pending·0 cites
- 3750US12508262B2Methods of using ALK2 inhibitorsKEROS THERAPEUTICS INC·Filed 2021·Granted Dec 30, 2025·0 cites·2 claims
- 3848US2025270287A1Activin receptor type ii chimeras and methods of use thereofKEROS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3948US2025188148A1Methods of administering an activin receptor type iib variantKEROS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4043US2018200308A1Methods of treating colitisSERES THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jennifer Lachey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →